Hot pharmaceutical products for this special time
Antiviral
fapilavir
At present, clinical trials of fapilavir are carried out in Shenzhen. "On the 3rd to 4th days after treatment, the viral nucleic acid negative rate of the medication group was significantly higher than that of the control group." According to the official websites of the United States Clinical Trial Registry and the Chinese Clinical Trial Registry, there are currently three clinical trials of fapilavir for the treatment of COVID-19.
Oseltamivir

Antipyretic analgesia
Paracetamo
Antibiotic
Levofloxacin hydrochloride

to get the product you want with a lower price.
If you are looking for the above products, make a quick inquiry now!
Looking for chemical products? Let suppliers reach out to you!
2026-06-25
-
Life Sciences Industry Overview
The coverage spans the global life sciences industry across pharmaceuticals and food & nutrition, tracking the shift from lowest-cost sourcing to supply continuity, quality, and risk management, along with product trends and the growing edge of differentiated, globally capable players.Published in: June.2026
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
Get More About Antipyretic
-
What Are Clindamycin Phosphate Gel Uses
-
Do You Know Any Clindamycin Phosphate Side Effects?
-
In the 'no resistance' era, citral is promising!
-
Antibacterial, antiviral, lactoferrin have so many uses!
-
Analysis of Hot Varieties in Antiviral Raw Material Market
-
API Supplier Audits Move to the Center of Pharma Supply Resilience
-
FDA Fee Updates Raise the Cost of Entering the U.S. Generic Drug Chain
-
FDA’s Warning to Compounders Raises the Stakes for API and Excipient Suppliers
-
BASF’s Price Increase Shows Pharma Excipients Are Still Exposed to Chemical Cost Pressure
Recommend Reading
-
Lilly’s Indiana Investment Puts API Capacity at the Center of Obesity Drug Competition
-
West Asia Tensions Squeeze Pharma Raw Materials
-
Pharmaceutical Tariffs Put Ingredients Back in Focus
-
IPEC Updates Excipient Qualification Guidance
-
India Accuses Balaji Amines of Manufacturing Pharma-Grade Propylene Glycol Without Drug Manufacturing Licence
-
L Catterton to Acquire Minority Stake in Perfume Company EX NIHILO
-
Demand Fluctuations Drive Butadiene Market to Soar in August
-
FDA Dye Pledges Push Natural Colors Into the Mainstream
-
$530 Million Lawsuit Unheard, $76 Million Counterclaim Filed: Is Qicai Chemical’s ‘Reputation Defense’ a Desperate Last Stand or a Calculated PR Gambit?
-
August Epichlorohydrin Market Shows a "V" Shaped Trend in China